Skip to main content
. 2010 Mar 8;54(5):2125–2134. doi: 10.1128/AAC.01420-09

TABLE 1.

Bacterial strains and plasmids used in this study

Group Genotype or relevant characteristic(s) Reference or source
E. coli strains used for mutagenesis
    HdeA100 GC4468 zdd-239::Tn9 del1738 (Δ39 kb, including marRAB locus) (Chlr) hdeABp::lacZ (Ampr) on λ at λatt site/pMB102 42
    HdeA100 mutants HdeA100 mutagenized using EZ-TN5 <R6Kγori/KAN-2> or EZ-TN5 <Kan-2> transposomes; Ampr Chlr Kanr This study
E. coli strains used for multidrug resistance and gene expression experiments
    BW25113 Wild type; F λ Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) rph-1 Δ(rhaD-rhaB)568 hsdR514 CGSC; 3
    JW5248 BW25113 ΔmarR::kan; Kanr CGSC; 3
    CR1000 BW25113 ΔmarR This study
    CR2000 BW25113 ΔmarRA This study
    CR1000/CR2000 inactivation mutants Kanr P1 HdeA100 mutant × CR1000/CR2000
Complementation plasmids Ptac lacIq; low copy number; Ampr Mobile plasmid collection
    pNTR-SD (control)     NBRP (E. coli) (NIG,
    pNT3-crp     Japan); 43
    pNTR-SD-hns
    pNTR-SD-cyaA
    pNT3-pcnB
    pNTR-SD-acrB
    pNTR-SD-tolC
    pNTR-SD-damX
Other plasmids
    pCP20 Plasmid for excision of kan and cat markers by FLP-mediated site-specific recombination; Ampr Chlr 12
    pKD3 Template for amplifying the cat gene; Chlr 12
    pKD46 λRed recombinase expression plasmid; Ampr 12
    pMB102 ori colE1 lacI lacZp::marA; Ampr 40
    pNN608 Single copy; acrAp-lacZ; Chlr 30